中国生物医药产业报告2009-2010

相似文件 换一批

是 否 +2 论坛币

k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

全球生物医药产业发展概述·····················································3
(一) 发展现状················································································3
1、产业规模············································································3
2、产业结构············································································4
(二) 基本特点················································································9
1、大型生物医药企业掀起并购重组热潮········································9
2、发展中国家成为国际医药外包热点········································· 11
3、资源整合加速产业聚集························································ 12
4、联盟合作成为重要研发模式·················································· 13
(三) 主要国家和地区发展概要························································· 13
1、美国：胚胎干细胞领域的研究政策逐步放开····························· 13
2、印度：生物医药研发投入大幅增加········································· 14
3、俄罗斯：鼓励创新药制造商本土化········································· 15
4、肯尼亚：药品市场复苏 将高速稳定增长································· 16
5、英国：欲扩大仿制药使用范围··············································· 16
二、2009年中国生物医药产业发展状况··················································· 18
(一) 发展现状·············································································· 18
1、产业规模·········································································· 18
2、产业结构·········································································· 18
3、产业环境·········································································· 19
(二) 基本特点·············································································· 21
1、已成为亚洲医药研发外包首选地············································ 21
2、产业集中度与创新能力有待提高············································ 21
3、生物医药产业基地方兴未艾·················································· 22
(三) 重点省市发展概要·································································· 23
1、北京：首都特色，产业集聚·················································· 23
2、上海：投资引导，平台完善·················································· 25
3、广东：起步较早，发展迅速·················································· 25
4、湖北：园区发展，研发力强·················································· 26
5、云南：原材料丰富，自主创新··············································· 27
三、2010－2012年中国生物医药产业发展预测········································· 28
(一) 影响因素·············································································· 28
1、有利因素·········································································· 28
2、不利因素·········································································· 28
(二) 产业规模预测········································································ 30
(三) 产业结构预测········································································ 30
四、2009年中国生物医药产业热点领域与市场分析···································· 32
(一) 基因工程药品行业·································································· 32
1、行业规模·········································································· 32
2、行业结构·········································································· 32
(二) 诊断试剂行业········································································ 34
1、行业规模·········································································· 34
2、行业结构·········································································· 35
(三) 抗体行业·············································································· 36
1、行业规模·········································································· 36
2、行业结构·········································································· 37
(四) 疫苗行业·············································································· 38
1、行业规模·········································································· 38
2、行业结构·········································································· 38
(五) 血液制品行业········································································ 39
1、行业规模·········································································· 39
2、行业结构·········································································· 41
五、2009年中国生物医药产业投资与竞争分析·········································· 44
(一) 政府投资重点分析·································································· 44
1、生物医药作为战略性新兴产业，政府将加大资金投入 ················ 44
2、传染病诊断试剂将成政府投资重点········································· 44
(二) VC/PE投资分析······································································ 45
1、积极政策吸引大量风投························································ 45
2、新药研发领域投资偏少························································ 46
3、医疗健康等领域受青睐························································ 46
(三) 重点企业竞争分析·································································· 46
1、主力品牌分布···································································· 47
2、华兰生物：以主力产品挖掘潜在市场······································ 48
3、科华生物：以核心技术夯实产业地位······································ 49
4、天坛生物：以新品研发占据市场先机······································ 50
5、双鹭药业：以渠道营销开辟发展空间······································ 51

扫码加我 拉你入群

请注明：姓名-公司-职位

以便审核进群资格，未注明则拒绝

分享0 收藏4 回帖

关键词：生物医药产业 生物医药 产业报告 医药产业 战略性新兴产业 中国 生物医药

好东西，非常感谢！

好东西，有一个总的就好了

分值不少，如果是打包成一个文件就好了

确实是个好东西

很不错的资料，谢谢

thanks a lot

thanks a lot

thanks a lot

应该打包一起！！还不错！！